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SUMMARY
Introduction Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease with 
a variety of oral manifestations (dry mouth, reduced salivary flow, painful mucosal lesions and restricted 
mouth opening, impaired oral hygiene maintenance), as well as possible far-reaching systemic implica-
tions. In the context of SLE, oral rehabilitation with dental implants might be the most appropriate solu-
tion. However, a lack of available literature, as well as the absence of treatment protocols, often leads to 
unsatisfactory management of these patients. 
The aim of this paper was to describe oral rehabilitation of a patient with SLE using dental implants and 
fixed dentures in both jaws.
Case outline A 66-year-old female patient, who had suffered from SLE for over 30 years, was referred for 
oral rehabilitation as her chief complaints related to the existing mobile partial dentures in the jaws and 
poor chewing ability. Proposed oral rehabilitation with fixed dentures supported by six dental implants in 
the maxilla and four dental implants in the mandible, as well as prosthetic restoration of the mandibular 
teeth, was accepted by the patient. During the follow-up period of three years, no biological complica-
tions were observed related to the performed treatment.
Conclusion Dental implants might be the most suitable treatment modality for oral rehabilitation of 
patients suffering from SLE. 
Keywords: dental implants; oral rehabilitation; systemic lupus erythematosus
INTRODUCTION
Systemic lupus erythematosus (SLE) is a 
chronic, autoimmune, inflammatory disease 
with multiple organ involvement and a broad 
spectrum of clinical manifestations, including 
mucocutaneous, cardiac, renal, pulmonary, and 
musculoskeletal complications [1]. The hall-
mark of this relapsing and remitting disease is 
the production of autoantibodies and immune 
complexes, with a consequent inflammatory 
response that may lead to cell death and organ 
failure [2].
Orofacial structures and functions may 
be adversely affected in the presence of SLE. 
Intraoral manifestations are most frequently 
presented as painful erythematous erosions, 
ulcerations and/or leukoplakic areas, localized 
on buccal, labial, lingual or palatal mucosa 
[1–3]. The most frequent complaints include 
xerostomia and burning mouth syndrome, 
while desquamative gingivitis, marginal gin-
givitis, and periodontitis are among common 
findings [1, 3–6]. Musculoskeletal complica-
tions may involve painful temporomandibular 
joint dysfunction, with possible repercussions 
on intraarticular mechanics. Additionally, im-
munosuppressive therapy, including cortico-
steroids and cytotoxic agents, poses a risk of 
inducing osteoporosis and altered immune 
response, with an increased susceptibility to 
oral infections [3]. Regarding reduced salivary 
flow, painful mucosal lesions may develop and 
impair oral hygiene regimen; often associated 
with restricted mouth opening and possible ad-
verse effects of immunosuppressive therapeutic 
agents. Therefore, providing satisfactory oral 
rehabilitation of patients with SLE might prove 
challenging.
The main objective of this paper was to pres-
ent the case of a patient with SLE, for whom 
oral rehabilitation with implant-supported 
fixed dentures was chosen as a treatment mo-
dality for partial edentulism. Considerations 
in regard to SLE complications and their pos-
sible impact on oral rehabilitation with dental 
implants were also discussed.
CASE REPORT
A 66-year-old female patient was referred for 
oral rehabilitation as her chief complaints re-
lated to the existing mobile partial dentures 
in jaws and poor chewing abilities. Medical 
records showed that the patient had suffered 
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from SLE for over 30 years. Treatment modality for SLE 
included 400 mg of hydroxychloroquine per day (Plaque-
nil, 200 mg tablets; Sanofi-Aventis, London, UK). Also, the 
patient was diagnosed with antiphospholipid syndrome 
treated with low doses of acetylsalicylic acid (Aspirin, 81 
mg tablets; Bayer Pharma AG, Leverkusen, Germany; one 
tablet daily). Regarding other significant comorbidities, 
the patient had suffered from diabetes mellitus type 2 
(DMT2) for 25 years. Metabolic control regarding DMT2 
was satisfactory with glycosylated hemoglobin level < 8%, 
without microvascular and macrovascular complications 
registered in the patient’s medical record, and DMT2 ther-
apy consisted of diet, oral hypoglycemic agent metformin 
(Glucophage SR, 750 mg tablets; Merck Pharmaceuticals, 
UK; two tablets daily) and long-acting insulin analogue 
(Lantus SoloStar 100 unit/ml solution, Sanofi-Aventis; 
36 units daily). A further daily therapy regimen included 
nifedipine with extended release (Adalat LA, 60 mg tablets; 
Bayer House, UK; one tablet daily) and atenolol (Atenolol, 
50 mg tablets, Actavis, UK; one tablet daily) for essential 
hypertension treatment, as well as calcium + vitamin D3 
supplements (Calcium 600 mg +D3, 600 mg – 200-unit 
tablets; Major Pharmaceuticals, Livonia, MI, USA; one 
tablet daily) for osteopenia.
Extraoral clinical inspection did not demonstrate facial 
skin involvement. Intraoral clinical examination presented 
characteristic bilateral discoid and pigmented lesions in-
volving buccal mucosa, reddened tongue with atrophy of 
the filiform papilla and sore mouth, with no ulcerations 
observed (Figure 1). The patient complained of symptoms 
similar to burning mouth syndrome (BMS), especially 
when consuming acidic or spicy food, difficulties in swal-
lowing, and dry mouth. However, after salivary flow mea-
surement according to the protocol described by Speight 
et al. [7], the obtained unstimulated saliva flow rate was 
0.2 mL/minute. A problem with limited mouth opening 
was also reported by the patient, as well as the slight pain 
in the temporomandibular joints (TMJ) while chewing. 
Clinical examination of the TMJ did not reveal signs of 
dislocation, subluxation, or crepitation during mandibular 
movements. Maximal inter-incisal distance was 24 mm. In 
the maxilla, only two teeth were present (the second molar 
and canine on the left side); in the mandible, both central 
and lateral incisors were present, as well as the canine and 
second premolar on the left side. 
Periodontal examination in the maxilla revealed se-
vere bone loss, furcation involvement, and pathological 
mobility of the second molar, while the canine exhib-
ited pathological mobility (an average probing depth of 
6.73 mm), and both were determined as irrational for fur-
ther treatment. In the mandible, gingivitis was present for 
an average probing depth of 1.62 mm. Moreover, bleeding 
on probing was observed in both maxillary teeth, as well 
as in central and lateral incisors on the right side in the 
mandible.
After taking into account medical history and intra-
oral status, proposed oral rehabilitation with fixed den-
tures supported by six dental implants in the maxilla and 
four dental implants in the mandible, as well as prosthetic 
restoration of the mandibular teeth, was accepted by the 
patient.
Preoperative treatment
The patient underwent the hygienic phase of periodon-
tal treatment, including extraction of the teeth that were 
determined as irrational for treatment (maxillary molar 
and canine) and scaling and polishing of the remaining 
teeth; root debridement was also done under local anes-
thesia (the left canine and the right lateral incisor in the 
mandible). Additionally, chlorhexidine 0.12% solution 
was prescribed to the patient to rinse twice daily for four 
weeks. The patient was advised not to wear partial den-
tures two weeks prior to surgery. After the hygienic phase 
and a four-week observation period, teeth preparation in 
the mandible was performed and temporary polymethyl 
methacrylate crowns were delivered.
On the morning of the surgical procedure, fasting plas-
ma glucose level was determined and the obtained value 
was 6.9 mmol/L. The patient also confirmed that she regu-
larly took prescribed therapy for autoimmune, metabolic, 
and cardiovascular disorders.
Surgical procedure
The surgical procedure was performed under local anes-
thesia. Previous partial dentures were modified and used 
as a template in order to more precisely transfer prosthetic 
planning during implant insertion. Midline crestal inci-
sion was performed in the maxilla; the mucoperiosteal 
flap was elevated and six implants (Straumann® Standard 
Plus, SLA, Basel, Switzerland) were installed according to 
manufacturer instructions in positions 16, 14, 12, 22, 24 
(4.1 mm in diameter; 10 mm in length), and 26 (4.8 mm 
in diameter; 6 mm in length). In the mandible, in the same 
manner, four implants (Straumann® Standard Plus, SLA) 
were placed in positions 46, 45 (4.8 mm in diameter; 6 
mm in length), 43 (4.1 mm in diameter; 10 mm in length) 
and 36 (4.8 mm in diameter; 8 mm in length and 6.5 mm 
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and the wounds were closed with monofilament sutures. 
No complications were observed during the surgery. A 
control panoramic X-ray was obtained immediately after 
surgery to ensure adequate implant placement (Figure 2).
Postoperative treatment
The postoperative regimen included antimicrobial therapy 
with 1 g of penicillin (Panclav, Hemofarm A.D., Vršac, 
Serbia) with probiotic prophylaxis, twice daily for five 
days and an antiseptic mouthwash (chlorhexidine 0.12% 
solution) twice daily for ten days. For postoperative pain 
control, rescue analgesics (Diclofenac Duo®, 75 mg, Phar-
maswiss, Nové Město, Czech Republic) were advised. The 
postoperative course proved uneventful and sutures were 
removed after eight days. A provisional denture was de-
livered for the upper jaw.
Prosthetic treatment
In the mandible, both central incisors were extracted due 
to unsuccessful endodontic treatment. Definitive implant-
supported fixed denture in the maxilla, and two implant- 
and one tooth-supported fixed restorations in the man-
dible were delivered nine months after surgery, following a 
delayed implant loading protocol. Inter-arch distance was 
determined precisely, having in mind the TMJ problems 
that were previously detected. Bilaterally balanced occlu-
sion was obtained during eccentric movements in order 
to minimize lateral forces.
During the 36-month follow-up period, no major com-
plications occurred (Figure 3). After nine months, ceramic 
chipping was observed on one tooth, which was repaired 
during the same visit. Periodontal examination revealed no 
gingivitis, periodontitis, or periimplantitis. Additionally, the 
patient reported no subjective symptoms such as a burning 
sensation or difficulty in eating, and overall improvement 
and satisfaction with fixed restorations were noticeable.
DISCUSSION
Impl ant treatment for patients suffering from SLE is not 
documented to a satisfactory extent in current literature. 
Moreover, no clear clinical guidelines are available regard-
ing this topic, which can lead to possible mistreatment of 
patients. In this paper, the case of uneventful installation 
of dental implants and successful prosthetic rehabilitation 
of a patient with SLE was presented, and specific consider-
ations with which a dentist should be familiar when treat-
ing such patients were pointed out.
Pathogenesis of SLE includes deposition of autoim-
mune antibody complexes in the connective tissue of 
various organs with subsequent immune response, and 
almost 90% of those affected are women ranging from 
young to middle age [8]. The presence of SLE may impair 
orofacial structures and functions in various ways. Major 
complaints include xerostomia, burning and tingling of 
oral mucosa, and painful mucosal lesions [1]. A patient’s 
discomfort is aggravated by mobile dentures that constant-
ly irritate oral mucosa, thus leading to a poorer quality of 
life. In the presented case, typical bilateral, painful mucosal 
lesions localized on buccal mucosa were confirmed, with 
symptoms of xerostomia and sore mouth, as well as the 
presence of unsatisfactory mobile dentures. Xerostomia, 
as the most common oral symptom in patients with SLE, 
is attributed secondarily to Sjogren’s syndrome, but this 
diagnosis was not confirmed from the patient’s medical 
chart [9]. Although the patient reported a subjective feel-
ing of dry mouth, hyposalivation was not confirmed by 
measuring the resting saliva flow, since the obtained saliva 
volume was higher than 0.1 ml/minute. In this case, the 
presence of SLE was accompanied by long-term DMT2, 
which could also contribute to the aggravation of orofa-
cial symptoms. It is reported that DMT2 by itself, due to 
underlying neuropathic and microvascular changes in oral 
tissues, may cause xerostomia, salivary gland dysfunction, 
periodontal disease, tooth loss, TMJ dysfunction, and 
burning and tingling of oral mucosa [10–14]. 
SLE may affect TMJ in up to 60% of patients, with pain-
ful and limited mouth opening [15]. The patient reported 
only slight pain bilaterally during mandibular movement 
with decreased interincisal distance. The observed condi-
tion was most probably due to tooth loss and inadequate 
interocclusal dimension achieved with previous remov-
able dentures, rather than SLE itself, since mouth open-
ing improved and interincisal distance increased after oral 
rehabilitation to 26 mm during the follow-up period. Also, 
the patient reported improvement in chewing, while pain 
during TMJ movement gradually disappeared. 
Frequent systemic complications of SLE include Lib-
man-Sacks endocarditis, which may be present in up to 
Figure 2. Postoperative panoramic X-ray Figure 3. Panoramic X-ray after three years 
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50% of patients. Deposition of autoimmune complexes in 
the endothelium of cardiac valves leads to nonbacterial 
thrombotic endocardial lesions, which may be colonized 
during transient bacteremia [16]. Therefore, oral surgi-
cal treatment of such a patient would require antibiotic 
prophylaxis. Since there was no endocardial involvement 
recorded in the patient’s medical chart, antibiotic prophy-
laxis was not performed. However, the usual postoperative 
antimicrobial regimen was prescribed. 
Antiphospholipid syndrome, also known as a lupus 
anticoagulant syndrome, is an autoimmune prothrom-
botic disorder with deep venous thrombosis as the most 
frequent clinical manifestation. SLE is the most common 
cause of secondary antiphospholipid syndrome, since 
it affects 30–60% of patients suffering from SLE [17]. 
Thrombotic tendency in venous, arterial, or microcircu-
latory vascular beds is a consequence of antibodies binding 
with the phospholipids in the platelets’ membrane, lead-
ing to increased activation and aggregation of platelets. 
The patient was treated daily with 81 mg of Aspirin, since 
these low doses (up to 100 mg per day) are effective in 
the prevention of thromboembolic episodes [17, 18]. Ad-
verse bleeding events were not observed intraoperatively 
or postoperatively, and hemostasis was obtained with usual 
local hemostatic measures. During outpatient dental sur-
gery, it is not recommended to interrupt low-dose Aspirin 
therapy in patients at risk of thromboembolic events, since 
local hemostatic measures are usually effective if intraop-
erative or postoperative bleeding occurs [19]. 
Osteopenia and osteoporosis are considered a signifi-
cant comorbidity of SLE and decreased bone mineral den-
sity may be present in up to 67% of women with SLE [20]. 
Corticosteroid therapy is regarded as one of the major 
risk factors, but other factors such as early menopause, 
renal impairment, low levels of vitamin D, lupus dura-
tion and older age may also contribute to the risk [21]. In 
the presented case, where the patient also suffered from 
osteopenia, SLE was treated with an antimalarial agent, 
and corticosteroids were not included in regular therapy. 
Antimalarial therapy is proven to be safe with respect to 
spine and hip-bone mineral density in female patients 
with SLE, although there is no data available concerning 
the impact of antimalarials on jaw bone metabolism [22]. 
While it is well documented that the presence of DMT2 
may lead to altered bone metabolism, it seems that DMT2 
does not impair mandibular bone mineral density [23]. 
In this case, it was not observed that the presence of SLE 
and the prescribed antimalarial therapy affected the os-
seointegration of dental implants and soft tissue healing 
over a 36- month follow-up period. Likewise, no signs of 
periimplantitis were noticed during functional loading 
during the same observation period.
Recently, Ergun et al. [24] also reported implant-sup-
ported prosthetic rehabilitation of a middle-aged female 
patient with SLE. The patient’s complaints were similar 
to those experienced by the patient in this case, includ-
ing xerostomia, sore mouth, and difficult opening of the 
mouth. However, characteristic mucosal lesions were more 
pronounced, involving hard palate and lips’ mucosa. After 
the uneventful installation and healing of six implants in 
the posterior parts of both jaws, fixed implant-supported 
restorations were delivered. At the end of a 24-month fol-
low-up period, the authors concluded that rehabilitation 
was successful, with improvements regarding subjective 
symptoms and limited mouth opening, and proposed that 
dental implants may be successful and preferred treatment 
option in patients with SLE. Correspondingly, in the pre-
sented case, clinical and radiographic findings revealed 
that peri-implant bone levels, as well as soft tissue volume 
remained stable after a 36-month follow-up period.
In conclusion, on the basis of currently limited data, 
clinicians might consider dental implants as probably the 
most satisfactory treatment modality when planning pros-
thetic rehabilitation for patients suffering from SLE. The 
present report showed an uneventful follow-up period of 
three years, with only minor dental complications observed 
(ceramic chipping). Regarding oral manifestations of SLE 
and imposed challenges in oral rehabilitation, fixed dentures 
supported by implants or teeth should be the therapeutic 
goal. SLE is characterized by multiple systemic complica-
tions and often accompanied by concomitant chronic dis-
eases, which may affect physical condition to varying de-
grees, and meticulous assessment of each individual patient 
is necessary before any procedures are performed. Further 
clinical trials are warranted, to result in clear guidelines for 
clinicians regarding implant treatment of patients with SLE.
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САЖЕТАК
Увод Системски еритематозни лупус (СЛЕ) јесте хронично 
аутоимуно обољење са различитим системским и оралним 
манифестацијама (ксеростомија, болне слузокожне лезије 
и болно отварање уста, отежано спровођење адекватне 
оралне хигијене), као и могућим системским комплика-
цијама.
Орална рехабилитација болесника са СЛЕ фиксним зубним 
надокнадама ношеним зубним имплантатима може пред-
стављати најприкладнији вид терапије. Међутим, услед 
ограничених информација из доступне литературе, као и 
недостатка терапијских протокола,  и данас се у пракси ови 
болесници неадекватно протетски збрињавају мобилним 
надокнадама. 
Циљ овог рада је био да прикаже болесницу оболелу од СЛЕ 
која је збринута фиксним зубним надокнадама ношеним 
зубним имплантатима у обе вилице.
Приказ болесника Жена, 66 година стара, са еволуцијом 
СЛЕ од 30 година, упућена је на оралну рехабилитацију због 
проблема са мобилним парцијалним протезама обе вилице 
и немогућности жвакања. Прихватила је препоручену орал-
ну рехабилитацију са шест денталних имплантата у горњој 
и четири у доњој вилици. Током периода праћења од три 
године нису уочене биолошке компликације.
Закључак Терапија зубним имплантатима се може сматрати 
најбољим терапијским модалитетом у оралној рехабилита-
цији болесника оболелих од СЛЕ. 
Кључне речи: зубни имплантати; орална рехабилитација; 
системски еритематозни лупус
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